Transforming Discovery into Opportunity

Karimah Es Sabar Named as the 2016 Honouree by Women Against MS (WAMS)


Vancouver, Canada – May 19, 2016: The MS Society of Canada, BC & Yukon Division is thrilled to announce Karimah Es Sabar, President and CEO of The Centre for Drug Research and Development, as the 2016 Honouree for the Women Against MS (WAMS) luncheon.  Women Against MS unites women to fight against a disease that universally and disproportionately affects women up to three times as much as men.

The MS Society of Canada and the Centre for Drug Research and Development (CDRD) formed a partnership in 2014 to accelerate the pace of MS Research in Canada. Establishing this partnership with CDRD has enabled the MS Society to leverage the tools and expertise needed to achieve its goal of developing treatments that will enhance the quality of life of people living with MS. For people living with progressive forms of MS (a type of MS marked by advanced disability), the potential benefits of translational research is monumental.

One of the driving forces behind this partnership has been the President & CEO of the CDRD, Karimah Es Sabar.  Ms. Es Sabar is a highly-recognized Canadian life sciences leader with broad global experience. She has had a successful career spanning start-up companies, multi-national pharmaceutical/ biotechnology companies, and not-for-profit organizations. Her support of the MS Society goes beyond this partnership. She was one of the Women Against MS committee members last year who helped to launch WAMS here in Vancouver.

“The choice to recognize of her as the 2016 WAMS Honouree is a celebration of her dedication and commitment to the MS cause as well as her role in the larger community as an inspiration to women in business everywhere.” shares Tania Vrionis, MS Society of Canada, BC & Yukon President.

“The MS Society and CDRD have combined forces in a unique partnership to accelerate translation and development of potential new discoveries. Their passion and commitment to their mission to find a cure for MS is inspiring. I’m very honoured to be recognized in this way,” says Karimah Es Sabar.

The WAMS Luncheon takes place on Thursday, November 17, 2016 at 12:00 pm in the Four Seasons Hotel Vancouver.  For tickets, visit or contact Stephanie Mosher at or 604-602-3208.

– 30 –

About Multiple Sclerosis and Women Against Multiple Sclerosis
Canada has the highest rate of multiple sclerosis in the world. MS is a chronic, often disabling disease of the central nervous system comprising the brain, spinal cord and optic nerve. It is one of the most common neurological diseases affecting young adults in Canada. Most people with MS are diagnosed between the ages of 15 and 40 and the unpredictable effects of MS last for the rest of their lives. Led by the Multiple Sclerosis Society of Canada, Woman Against Multiple Sclerosis (WAMS) is a collective of professional women committed to raising research funds to end MS while participating in exclusive networking opportunities. Through MS research-focused fundraising, WAMS strives to enable professional and personal growth for Canadian women. Funds raised by WAMS will be directed to a new generation of ground-breaking researchers in their endeavours to end MS. Please visit  or call 604-602-3208 to get involved or for more information.

Stephanie Mosher, MS Society of Canada, BC & Yukon Division

About CDRD:

Headquartered in Vancouver, The Centre for Drug Research and Development (CDRD) is Canada’s national drug development and commercialization engine. We work in partnership with academia, industry, government and foundations, and provide the specialized expertise and infrastructure to identify and de-risk promising discoveries, and transform them into commercially viable investment opportunities for the private sector – and ultimately into innovative new therapies for patients. In doing so, CDRD is actively growing our national health sciences industry into a wholly-optimized generator of economic prosperity for the country. Canada’s Networks of Centres of Excellence Program has recognized CDRD as a Centre of Excellence for Commercialization and Research (CECR).

Julia White
Manager, Communications, CDRD

Sign up to our newsletter

Receive CDRD's e-newsletter, The CDRD Pipeline and other e-communications for regular updates on all our news and activities.

© Copyright 2017 CDRD. All rights reserved.